Sclerostin: a possible target for the management of cancer-induced bone disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sclerostin: a possible target for the management of cancer-induced bone disease
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 16, Issue 8, Pages 761-769
Publisher
Informa Healthcare
Online
2012-07-05
DOI
10.1517/14728222.2012.697154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sclerostin is overexpressed by plasma cells from multiple myeloma patients
- (2011) Giacomina Brunetti et al. Annals of the New York Academy of Sciences
- The sclerostin-bone protein interactome
- (2011) Hemamalini Devarajan-Ketha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications
- (2011) Evangelos Terpos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
- (2011) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Advances in Imaging and the Management of Myeloma Bone Disease
- (2011) Evangelos Terpos et al. JOURNAL OF CLINICAL ONCOLOGY
- Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
- (2011) D. Cejka et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide
- (2011) S. A. Polyzos et al. OSTEOPOROSIS INTERNATIONAL
- Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/ -catenin signaling
- (2011) A. Scholer-Dahirel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sclerostin binds and regulates the activity of cysteine-rich protein 61
- (2010) Theodore A. Craig et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mesd Is a Universal Inhibitor of Wnt Coreceptors LRP5 and LRP6 and Blocks Wnt/β-Catenin Signaling in Cancer Cells
- (2010) Wenyan Lu et al. BIOCHEMISTRY
- Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats
- (2010) XiaoYan Tian et al. BONE
- Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
- (2010) Julie A. Sterling et al. BONE
- Sclerostin: Current Knowledge and Future Perspectives
- (2010) M. J. C. Moester et al. CALCIFIED TISSUE INTERNATIONAL
- Signaling pathways in renal cell carcinoma
- (2010) Gowrishankar Banumathy et al. CANCER BIOLOGY & THERAPY
- Metastasis and bone loss: Advancing treatment and prevention
- (2010) Robert E. Coleman et al. CANCER TREATMENT REVIEWS
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
- (2010) Ce Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Sclerostin and Dickkopf-1 in Renal Osteodystrophy
- (2010) D. Cejka et al. Clinical Journal of the American Society of Nephrology
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
- (2010) Ulrike I Mödder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
- (2010) Faryal S. Mirza et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
- (2010) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Wnt/beta-catenin pathway in adrenocortical development and cancer
- (2010) Abeer El Wakil et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Aberrant WNT/β-catenin signaling in parathyroid carcinoma
- (2010) Jessica Svedlund et al. Molecular Cancer
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin
- (2010) E Lavergne et al. ONCOGENE
- Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
- (2010) X Yu et al. ONCOGENE
- Osteocyte: the unrecognized side of bone tissue
- (2010) G. Y. Rochefort et al. OSTEOPOROSIS INTERNATIONAL
- Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
- (2010) S. A. Ettenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt signaling in stem and cancer stem cells
- (2010) Peter Wend et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy
- (2010) Allan Lipton SEMINARS IN ONCOLOGY
- A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
- (2010) Olivia M. Lucero et al. Current Oncology Reports
- Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients
- (2009) John P. Bida et al. MAYO CLINIC PROCEEDINGS
- Osteocytes, mechanosensing and Wnt signaling
- (2008) Lynda F. Bonewald et al. BONE
- Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases
- (2008) Guojun Bu et al. INTERNATIONAL JOURNAL OF CANCER
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Matrix Mineralization as a Trigger for Osteocyte Maturation
- (2008) Kazuharu Irie et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- The prognostic significance of BMP-6 signaling in prostate cancer
- (2008) Hiu-Fung Yuen et al. MODERN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started